Drug Type Antibody-photosensitizer conjugates |
Synonyms SGM 101 |
Target |
Action inhibitors |
Mechanism CEA inhibitors(Carcinoembryonic antigen inhibitors), Diagnostic dye |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rectal Cancer | Phase 3 | United States | 17 Jun 2019 | |
Rectal Cancer | Phase 3 | Germany | 17 Jun 2019 | |
Rectal Cancer | Phase 3 | Italy | 17 Jun 2019 | |
Rectal Cancer | Phase 3 | Netherlands | 17 Jun 2019 | |
Colorectal Cancer | Phase 3 | Australia | - | |
Pancreatic Cancer | Phase 3 | Australia | - | |
Gastrointestinal polyps | Phase 2 | Netherlands | - | 31 Jan 2024 |
Brain metastases | Phase 2 | Netherlands | 01 Jan 2024 | |
Colorectal Liver Metastases | Phase 2 | Netherlands | 01 Dec 2023 | |
Metastatic colon cancer | Phase 2 | Netherlands | 01 Nov 2020 |
Phase 1 | 10 | krbrudewsj(xovwloskqr) = nxjvtixybw mnfbgispjh (reebhbaiyz ) View more | - | 06 Aug 2022 |